Erik Harris - Feb 3, 2022 Form 3 Insider Report for Denali Therapeutics Inc. (DNLI)

Role
Director
Signature
/s/ Tyler Nielsen, by power of attorney
Stock symbol
DNLI
Transactions as of
Feb 3, 2022
Transactions value $
$0
Form type
3
Date filed
2/7/2022, 05:51 PM
Previous filing
Oct 18, 2021
Next filing
Feb 14, 2022

No securities are beneficially owned.